New method of targeting mutant RAS protein provides hope for cancer patients
As a 10-year journey comes to fruition, Medical University of South Carolina (MUSC) Hollings Cancer Center researcher John O'Bryan, Ph.D., and colleagues have demonstrated a new therapeutic way to block a protein that is ...
Feb 8, 2022
0
64